Neurosurgery Supports the BRAIN Act

Introduced on Sept. 30 by Rep. Earl Blumenauer (D-Ore.), the Bringing Regulatory Advances Into Neuroscience (BRAIN) Act (H.R. 5435) would authorize $25 million and direct the Food and Drug Administration (FDA) to establish a Neuroscience Center of Excellence. This new center would coordinate activities within the FDA to create a more collaborative and innovative process to develop crucial treatments and cures that target the brain and central nervous system. This would specifically include those conditions with few or no approved treatments, as they take longer to develop and are less likely to be approved than treatments for other disease areas.

Click here to read the AANS/CNS letter of support.